16th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
February 26-28, 2017 • Atlanta, GA
| Cochlear Implantation in Children with Congenital Cytomegalovirus
Cochlear Implantation in Children with Congenital Cytomegalovirus
Congenital cytomegalovirus (CMV) infection is the leading cause of non-genetic sensorineural hearing loss (SNHL) in the United States. It is estimated that 30,000–40,000 infants are affected each year by congenital CMV infection with approximately 8,000 developing SNHL and/or permanent neurological defects. At our center, children with congenital CMV who receive cochlear implants have shown wide variability in performance. This poster will examine outcomes of cochlear implantation for approximately 75 children with a diagnosis of congenital CMV who received cochlear implants and are currently being followed at the Children’s Cochlear Implant Center at UNC. Dependent variables will include birth history, age of diagnosis, age of implantation, type of device, speech perception outcomes, and comorbidities associated with congenital CMV.
- 1. Participants will be able to differentiate between a symptomatic and asymptomatic newborns infected with CMV.
- 2. Participants will be able to describe cochlear implant performance in a cohort of children with congenital CMV.
- 3. Participants will be able to identify comorbidities identified in a cohort of children with congenital CMV.
Presentation:
This presentation has not yet been uploaded or the speaker has opted not to make the presentation available online.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Lisa Copeland
(), UNC School of Medicine, lisa_copeland@med.unc.edu;
Lisa is a full-time graduate student in UNC's AuD program and a LEND audiology trainee at the Carolina Institute for Developmental Disabilities
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Holly Teagle
(), UNC-Chapel Hill, holly_teagle@med.unc.edu;
Dr. Teagle is Associate Professor of Otolaryngology and Co-Director of the Children's Cochlear Implant Center at UNC.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Jackson Roush
(), University of North Carolina - Chapel Hill, jroush@med.unc.edu;
Dr. Roush is Professor and Director of the Division of Speech and Hearing Sciences, University of North Carolina School of Medicine, Chapel Hill, NC. He also serves as Director of the North Carolina LEND program and is co-chair of the NC EHDI Advisory Board. Dr. Roush has been a pediatric audiologist for 35 years.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.